Anti‐spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents
Background Duration of post‐vaccination protection against COVID‐19 in nursing home
(NH) residents is a critical issue. The objective of this study was to estimate the duration of …
(NH) residents is a critical issue. The objective of this study was to estimate the duration of …
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April-August 2021
B de Gier, M Kooijman, J Kemmeren, N de Keizer… - MedRxiv, 2021 - medrxiv.org
The objective of this study was to estimate vaccine effectiveness (VE) against COVID-19
hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant …
hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant …
Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population cohort study
P Nordström, M Ballin, A Nordström - Hospitalization, and Death …, 2021 - papers.ssrn.com
Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19)
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England
TFD Mason, M Whitston, J Hodgson, RE Watkinson… - BMC medicine, 2021 - Springer
Abstract Background The BNT162b2 mRNA vaccine has been shown to be effective at
preventing serious COVID-19 events in clinical trials. There is less evidence on …
preventing serious COVID-19 events in clinical trials. There is less evidence on …
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November …
J Starrfelt, AS Danielsen, EA Buanes, LK Juvet… - BMC medicine, 2022 - Springer
Background COVID-19 vaccines have been crucial in the pandemic response and
understanding changes in vaccines effectiveness is essential to guide vaccine policies …
understanding changes in vaccines effectiveness is essential to guide vaccine policies …
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in …
B Nunes, AP Rodrigues, I Kislaya, C Cruz… - …, 2021 - eurosurveillance.org
Through deterministic data linkage of health registries, mRNA vaccine effectiveness (VE)
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older …
against COVID-19-related hospitalisations and deaths was measured in 1,880,351 older …
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023
M Fontán-Vela, E Kissling, N Nicolay… - …, 2024 - eurosurveillance.org
To monitor relative vaccine effectiveness (rVE) against COVID-19-related hospitalisation of
the first, second and third COVID-19 booster (vs complete primary vaccination), we …
the first, second and third COVID-19 booster (vs complete primary vaccination), we …
Effectiveness of a fourth dose of COVID-19 vaccine among long-term care residents in Ontario, Canada: test-negative design study
R Grewal, SA Kitchen, L Nguyen, SA Buchan… - medRxiv, 2022 - medrxiv.org
Abstract Background As of December 30, 2021, Ontario long-term care (LTC) residents who
received a third dose of COVID-19 vaccine≥ 84 days previously were offered a fourth dose …
received a third dose of COVID-19 vaccine≥ 84 days previously were offered a fourth dose …
[HTML][HTML] COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA. 5 circulation: cohort study based …
I Kislaya, A Machado, S Magalhães… - …, 2022 - eurosurveillance.org
We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in
elderly people in Portugal between May and July 2022. In≥ 80 year-olds, the second …
elderly people in Portugal between May and July 2022. In≥ 80 year-olds, the second …
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Summary Background Several SARS-CoV-2 variants of concern have been identified that
partly escape serum neutralisation elicited by current vaccines. Studies have also shown …
partly escape serum neutralisation elicited by current vaccines. Studies have also shown …